| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |